Exabis Library
Welcome to the e-CCO Library!
OP29: Peri-natal exposure to parental Crohn's disease is associated with impaired gut barrier, microbiome composition differences and increased risk of Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP29: Peripheral blood DNA methylation biomarkers accurately predict clinical- and endoscopic response to vedolizumab in a real-life cohort of Crohn’s Disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP29: ST2+/IL-33 responsive cells promote tumorigenesis in colitis-associated colorectal cancer
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP30 The interplay of microbiome dysbiosis and immune system deregulation in patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP30: Human umbilical cord mesenchymal stem cells derived exosomes alleviate Ulcerative Colitis by inhibiting macrophage ferroptosis via miR-23b-3p/Nrf2 pathway
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP30: Lyophilised orally administered faecal microbiota transplantation for Active Ulcerative Colitis (LOTUS study)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP30: Serum proteomic profiling predicts and diagnoses pouchitis in ulcerative colitis patients undergoing ileal pouch-anal anastomosis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP30: Upadacitinib modulates inflammatory pathways in gut tissue in patients with Ulcerative Colitis: Transcriptomic profiling from the Phase 2b study, U-ACHIEVE
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP31 Meta–omics reveals microbiome-driven proteolysis as a contributing factor to the severity of ulcerative colitis disease activity
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP31: Dietary and Multi-Omic characterization of new onset treatment naive Crohn Disease identifies factors that may contribute to disease pathogenesis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP31: High fat diet exacerbates colitis through microbial metabolite deoxycholic acids induced-ferroptosis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP31: RESTORE: Interim analysis of a Phase 2 study of QBECO SSI for the induction and maintenance of clinical and endoscopic remission in subjects with Moderate to Severe Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP31: TP53 mutation in human colonic organoids acquires resistance to in vitro long-term inflammation
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP32 Mincle signalling promotes intestinal mucosal inflammation through induction of macrophage pyroptosis and neutrophil chemotaxis in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP32: A novel mechanism of colonic epithelial-T-cell cross-talk is dysregulated in IBD
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP32: Pyroptosis Inhibition Prevents the Cytotoxicity Induced by IL-17 Without Impairing Its Beneficial Effects
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP32: Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn’s Disease patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP32: The gut virome-colonizing Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP33 Multi-omics analysis reveals specific bio-geographical and functional characteristics in inflammatory bowel disease intestinal mucosa
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP33: BUB1: a new player in the development of Crohn’s disease (CD)-associated fibrosis
2019
ECCO '19 Copenhagen
Thursday, 28 February 2019, 8:13 AM
1